LB-100
CAS: 1026680-07-8
Rif. 3D-BRB68007
| 5mg | 422,00 € | ||
| 10mg | 601,00 € | ||
| 25mg | 1.010,00 € | ||
| 50mg | 1.617,00 € | ||
| 100mg | 2.586,00 € |
Informazioni sul prodotto
- 7-Oxabicyclo[2.2.1]heptane-2-carboxylic acid, 3-[(4-methyl-1-piperazinyl)carbonyl]-, (1R,4S)-rel-
- rel-(1R,4S)-3-[(4-Methyl-1-piperazinyl)carbonyl]-7-oxabicyclo[2.2.1]heptane-2-carboxylic acid
- 3-[(4-Methylpiperazin-1-yl)carbonyl]-7-oxabicyclo[2.2.1]heptane-2-carboxylic acid
- LB 100
LB-100 is a low potency, orally available inhibitor of the polymerase chain reaction. LB-100 inhibits cell proliferation and induces apoptosis in vitro in miapaca-2 cells. It has been shown to inhibit tumor growth and induce antitumor response in mouse tumor models. LB-100 also reduces water vapor loss from the lungs, which is associated with bowel disease, hepatic steatosis, and radiation therapy. In a study of dinucleotide phosphate (DNP) induced hepatotoxicity in mice, LB-100 treatment prevented DNP-induced liver injury and death by inhibiting hepatic steatosis. LB-100 has shown efficacy against a variety of cancers including malignant brain tumors. This drug also has pharmacological effects on human cells that are specific to their tissue type or function.
Proprietà chimiche
Richiesta tecnica su: 3D-BRB68007 LB-100
Se si desidera richiedere un preventivo o effettuare un ordine, si prega invece di aggiungere i prodotti desiderati al carrello e poi richiedere un preventivo o un ordine dal carrello. È più veloce, più economico, e potrà beneficiare degli sconti disponibili e di altri vantaggi.
